Construction of a disease management program and evidences for preventing recurrence of stroke in community settings
- Conditions
- Stroke
- Registration Number
- JPRN-UMIN000007808
- Lead Sponsor
- Hiroshima University, Institute of Biomedical & Health Sciences
- Brief Summary
Regarding the primary end point, there was no significant difference in the changes in the Framingham risk score at any follow-up time between the groups. The incidence of stroke recurrence tended to be lower in the disease management program intervention group, although no significant difference was found (hazard ratio, 0.49; 95% CI, 0.19-1.29).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 321
Not provided
A patient (in modified Rankin Scale at the time of recruitment at levels of 4 or 5, 6) having severe complications and the physical symptom that the contents of the program cannot carry out. A patient (lower than Hasegawa-style intelligence evaluation scale (HDS-R) 20/30 mark) of the dementia. The patient who is undergoing medical treatment in rehabilitation wards, a medical treatment type wards and long-term care insurance facility. The terminal stage and a pregnant patient. Patients whose chief physicians judge that the enforcement of the program causes problems on the patients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Framingham Risk Score: general cardiovascular disease 10 year risk
- Secondary Outcome Measures
Name Time Method Cumulative incidence rate of stroke recurrence and the complication (cardiovascular disease) All-cause mortality Physiological indicators (Blood pressure, HbA1c, etc) Psychological indicators (self-efficacy, depression, QOL) Attainment rate of behavior modification